Prime Medicine, Inc. (PRME) has a market capitalization of $668.04M and trades at $3.70. The 52-week range is 1.11-6.94.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.7, Earnings Per Share (EPS) of $-1.35, annual revenue of $4.63M.
The stock has a beta of 2.67, operates in the Healthcare sector.
